Cargando…
Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs)
Advanced glycation end products (AGEs) are compounds classified as uremic toxins in patients with chronic kidney disease that have several pro-inflammatory effects and are implicated in the development of cardiovascular diseases. To explore the mechanisms of AGEs–endothelium interactions through the...
Autores principales: | Rempel, Lisienny C. T., Finco, Alessandra B., Maciel, Rayana A. P., Bosquetti, Bruna, Alvarenga, Larissa M., Souza, Wesley M., Pecoits-Filho, Roberto, Stinghen, Andréa E. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448170/ https://www.ncbi.nlm.nih.gov/pubmed/26008233 http://dx.doi.org/10.3390/toxins7051722 |
Ejemplares similares
-
Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease
por: Finco, Alessandra Becker, et al.
Publicado: (2016) -
Sevelamer reduces endothelial inflammatory response to advanced glycation end products
por: Gregório, Paulo C, et al.
Publicado: (2018) -
Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis
por: Pulito-Cueto, Verónica, et al.
Publicado: (2022) -
ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion
por: Li, Hailing, et al.
Publicado: (2012) -
Vascular Damage in Kidney Disease: Beyond Hypertension
por: Stinghen, Andréa E. M., et al.
Publicado: (2011)